Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-006682

Director acquired 1,250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Zhao Baiteng Director 2025-03-04 Grant or award +1,250,000 $2.40 $3,000,000 1,250,000 I
Loading xslF345X05/form4-03042025_110310.xml…